Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating flow measurement and ultrasound imaging in vein bypass surgery for limb ischemia

Official title: Open, Prospective, Multicentre Study Addressing the Immediate Benefits and the Prognostic Value of Intraoperative Completion Control Following Infrainguinal Bypass Surgery in Chronic Limb-Threatening Ischemia (CLTI) Patients

Run by Medistim ASA · NCT06264843 · Data updated 2026-11-12

This study is testing if using special tools to measure blood flow and take pictures of veins can help improve the results of vein bypass surgery for people with serious circulation problems in their legs.

More Chronic Limb-Threatening Ischemia trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment450 (estimated)
SponsorMedistim ASA
Industry-sponsored
Locations1 site (San Francisco, California)
StatusRecruiting
StartedNovember 14, 2024
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedOctober 14, 2025
Trial IDNCT06264843 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals diagnosed with chronic limb-threatening ischemia due to atherosclerotic infra-popliteal peripheral artery disease who have suitable vein conduits for bypass.

Probably not a fit

Patients with non-atherosclerotic lesions or those requiring bypass with artificial conduits will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify and validate the effectiveness of flow measurement and ultrasound imaging techniques in patients undergoing vein bypass surgery for chronic limb-threatening ischemia. The study will utilize MiraQ with Transit-Time Flow Measurement (TTFM) and L15 High Frequency Ultrasound (HFUS) probes to assess blood flow and vascular health. Participants will be monitored to gather data on the outcomes of their surgeries and the accuracy of these imaging methods.

Why it matters

Potential benefit: If successful, this study could enhance surgical outcomes and improve the management of patients with chronic limb-threatening ischemia.

How similar studies have gone: While this approach is innovative, similar studies have shown promise in improving surgical techniques and patient outcomes in vascular surgery.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Chronic Limb-Threatening Ischemia as defined by presence of Peripheral Artery Disease (PAD) in combination with rest pain, gangrene, or a lower limb ulceration\>2 weeks duration (ref Global Guidelines)
* Atherosclerotic infra-popliteal PAD
* Adequate distal anastomotic target (crural, tibial or popliteal below the knee with one single run-off) between knee and ankle distal to the stenotic/occluded segment.
* Available autogenous vein conduit based on preoperative vein mapping.
* Understand the nature of the procedure and willingness to comply with protocol. Attend follow-up appointments and provide written informed consent.

Exclusion Criteria:

* Bypass with artificial conduit or cryopreserved allografts
* Bypass for non-atherosclerotic lesions
* Life-expectancy less than 2 years
* Any psychological, developmental, physical or emotional disorder that the investigator believes would interfere with surgery or follow-up.
* Any condition that the investigator believes should exclude participation.
* Excessive risk for adverse events during open surgery as judged by the investigator.

Where it's running

  • University of California
    San Francisco, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.